|
Symbol |
Object Name |
Qualifiers
|
Evidence |
Notes |
Source |
PubMed Reference(s) |
RGD Reference(s) |
Position |
|
G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
multiple interactions affects activity increases expression decreases activity
|
ISO
|
Acetylcysteine inhibits the reaction [formononetin results in increased expression of ABCB1 mRNA]; formononetin inhibits the reaction [Epirubicin results in increased expression of ABCB1 mRNA]; formononetin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]] formononetin affects the activity of ABCB1 protein formononetin results in decreased activity of ABCB1 protein
|
CTD |
PMID:15796199 PMID:23867903 PMID:27996361 PMID:34217736 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G
|
Abcc1
|
ATP binding cassette subfamily C member 1
|
affects activity multiple interactions decreases expression
|
ISO
|
formononetin affects the activity of ABCC1 protein Acetylcysteine inhibits the reaction [formononetin results in decreased expression of ABCC1 mRNA]; formononetin inhibits the reaction [Epirubicin results in increased expression of ABCC1 mRNA]
|
CTD |
PMID:15796199 PMID:23867903 |
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114
|
|
G
|
Abcc2
|
ATP binding cassette subfamily C member 2
|
multiple interactions decreases expression
|
ISO EXP
|
Acetylcysteine inhibits the reaction [formononetin results in decreased expression of ABCC2 mRNA]; formononetin inhibits the reaction [Epirubicin results in increased expression of ABCC2 mRNA] formononetin promotes the reaction [Cisplatin results in increased expression of ABCC2 mRNA]
|
CTD |
PMID:23867903 PMID:28414026 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
|
|
G
|
Abcc4
|
ATP binding cassette subfamily C member 4
|
multiple interactions
|
EXP
|
formononetin promotes the reaction [Cisplatin results in increased expression of ABCC4 mRNA]
|
CTD |
PMID:28414026 |
|
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:95,542,315...95,774,283
|
|
G
|
Acp5
|
acid phosphatase 5, tartrate resistant
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [Streptozocin results in increased activity of ACP5 protein]; formononetin inhibits the reaction [Streptozocin results in increased expression of ACP5 mRNA]
|
CTD |
PMID:35315182 |
|
NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:20,663,985...20,667,929
|
|
G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions increases activity
|
ISO
|
fulvestrant promotes the reaction [formononetin results in increased activity of AHR protein]
|
CTD |
PMID:28985473 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
|
|
G
|
Akr1b10
|
aldo-keto reductase family 1 member B10
|
increases expression
|
ISO
|
formononetin results in increased expression of AKR1B10 mRNA
|
CTD |
PMID:37793997 |
|
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:63,040,169...63,053,852
|
|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions decreases phosphorylation
|
ISO
|
formononetin promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of AKT1 protein]; Wortmannin inhibits the reaction [formononetin promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of AKT1 protein]] formononetin decreases phosphorylation of AKT1 protein in lung
|
CTD RGD |
PMID:34077701 PMID:32276600 |
RGD:151357000 |
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions
|
ISO EXP
|
formononetin promotes the reaction [Epirubicin results in increased expression of BAX mRNA] formononetin inhibits the reaction [Cisplatin results in increased expression of BAX protein]
|
CTD |
PMID:23867903 PMID:28414026 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression multiple interactions
|
ISO EXP
|
formononetin results in decreased expression of BCL2 mRNA formononetin promotes the reaction [Cisplatin results in increased expression of BCL2 protein] formononetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]
|
CTD |
PMID:23867903 PMID:28414026 PMID:34077701 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions increases activity increases expression
|
ISO EXP
|
Acetylcysteine inhibits the reaction [formononetin results in increased expression of CASP3 mRNA]; Epirubicin promotes the reaction [formononetin results in increased activity of CASP3 protein]; Epirubicin promotes the reaction [formononetin results in increased expression of CASP3 mRNA]; formononetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP3 protein]; formononetin promotes the reaction [Epirubicin results in increased activity of CASP3 protein]; formononetin promotes the reaction [Epirubicin results in increased expression of CASP3 mRNA] formononetin inhibits the reaction [Cisplatin results in increased expression of CASP3 protein modified form] formononetin increases activity of CASP3 protein in lung
|
CTD RGD |
PMID:23867903 PMID:28414026 PMID:34077701 PMID:32276600 |
RGD:151357000 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G
|
Casp7
|
caspase 7
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP7 protein]
|
CTD |
PMID:34077701 |
|
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
|
|
G
|
Casp8
|
caspase 8
|
multiple interactions increases activity increases expression
|
ISO
|
Acetylcysteine inhibits the reaction [formononetin results in increased expression of CASP8 mRNA]; Epirubicin promotes the reaction [formononetin results in increased activity of CASP8 protein]; Epirubicin promotes the reaction [formononetin results in increased expression of CASP8 mRNA]
|
CTD |
PMID:23867903 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
|
|
G
|
Casp9
|
caspase 9
|
multiple interactions increases activity increases expression
|
ISO
|
Acetylcysteine inhibits the reaction [formononetin results in increased expression of CASP9 mRNA]; Epirubicin promotes the reaction [formononetin results in increased activity of CASP9 protein]; Epirubicin promotes the reaction [formononetin results in increased expression of CASP9 mRNA]; formononetin promotes the reaction [Epirubicin results in increased activity of CASP9 protein]; formononetin promotes the reaction [Epirubicin results in increased expression of CASP9 mRNA]
|
CTD |
PMID:23867903 |
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G
|
Ccnb1
|
cyclin B1
|
increases expression multiple interactions
|
ISO EXP
|
formononetin results in increased expression of CCNB1 protein XI-006 inhibits the reaction [formononetin results in increased expression of CCNB1 protein]
|
CTD |
PMID:28414026 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
|
|
G
|
Ccnd1
|
cyclin D1
|
increases expression multiple interactions
|
EXP ISO
|
formononetin results in increased expression of CCND1 protein XI-006 inhibits the reaction [formononetin results in increased expression of CCND1 protein]
|
CTD |
PMID:28414026 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
|
|
G
|
Cpt1a
|
carnitine palmitoyltransferase 1A
|
increases expression
|
ISO
|
formononetin results in increased expression of CPT1A mRNA
|
CTD |
PMID:37793997 |
|
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055
|
|
G
|
Ctsk
|
cathepsin K
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [Streptozocin results in increased expression of CTSK mRNA]; formononetin inhibits the reaction [Streptozocin results in increased expression of CTSK protein]
|
CTD |
PMID:35315182 |
|
NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:183,058,569...183,069,550
|
|
G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
increases hydroxylation decreases methylation multiple interactions increases expression
|
ISO
|
CYP1A1 protein results in increased hydroxylation of formononetin CYP1A1 protein results in decreased methylation of formononetin fulvestrant promotes the reaction [formononetin results in increased expression of CYP1A1 mRNA]
|
CTD |
PMID:15479032 PMID:28985473 PMID:37793997 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
|
|
G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
decreases activity
|
ISO EXP
|
formononetin results in decreased activity of CYP1A2 protein
|
CTD |
PMID:26278343 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
|
|
G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
decreases methylation increases expression
|
ISO
|
CYP1B1 protein results in decreased methylation of formononetin formononetin results in increased expression of CYP1B1 mRNA
|
CTD |
PMID:15479032 PMID:28985473 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917
|
|
G
|
Cyp2d4
|
cytochrome P450, family 2, subfamily d, polypeptide 4
|
decreases activity
|
ISO
|
formononetin results in decreased activity of CYP2D6 protein
|
CTD |
PMID:26278343 |
|
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
|
|
G
|
Egfr
|
epidermal growth factor receptor
|
decreases phosphorylation
|
ISO
|
formononetin decreases phosphorylation of EGFR protein in lung
|
RGD |
PMID:32276600 |
RGD:151357000 |
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
|
|
G
|
Epo
|
erythropoietin
|
increases expression
|
ISO
|
formononetin results in increased expression of EPO mRNA
|
CTD |
PMID:21309574 PMID:37348668 |
|
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:19,204,508...19,207,946
|
|
G
|
Esr1
|
estrogen receptor 1
|
affects binding multiple interactions
|
ISO
|
formononetin binds to ESR1 protein formononetin binds to and results in increased activity of ESR1 protein [Lipopolysaccharides co-treated with formononetin] results in increased expression of ESR1 protein
|
CTD |
PMID:9751507 PMID:16076101 PMID:16773531 PMID:37269934 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
|
|
G
|
Esr2
|
estrogen receptor 2
|
multiple interactions affects binding
|
ISO
|
formononetin binds to and results in increased activity of ESR2 protein formononetin binds to ESR2 protein
|
CTD |
PMID:9751507 PMID:12224631 PMID:16076101 PMID:16773531 PMID:19913605 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
|
|
G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [Streptozocin results in increased expression of FOS mRNA]; formononetin inhibits the reaction [Streptozocin results in increased expression of FOS protein]
|
CTD |
PMID:35315182 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
|
|
G
|
Gclm
|
glutamate cysteine ligase, modifier subunit
|
multiple interactions
|
ISO
|
[formononetin co-treated with Hydrogen Peroxide] results in increased expression of GCLM protein; formononetin promotes the reaction [Hydrogen Peroxide results in increased expression of GCLM mRNA]; NFE2L2 protein affects the reaction [formononetin promotes the reaction [Hydrogen Peroxide results in increased expression of GCLM mRNA]]; Wortmannin inhibits the reaction [formononetin promotes the reaction [Hydrogen Peroxide results in increased expression of GCLM mRNA]]
|
CTD |
PMID:34077701 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
|
|
G
|
Havcr1
|
hepatitis A virus cellular receptor 1
|
multiple interactions
|
EXP
|
formononetin inhibits the reaction [Cisplatin results in increased expression of HAVCR1 mRNA]
|
CTD |
PMID:28414026 |
|
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,119,088...31,151,698
|
|
G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
increases expression multiple interactions
|
ISO
|
formononetin results in increased expression of HIF1A mRNA; formononetin results in increased expression of HIF1A protein formononetin results in decreased degradation of and results in increased expression of HIF1A protein modified form; formononetin results in increased expression of and results in decreased degradation of HIF1A protein
|
CTD |
PMID:21309574 PMID:37348668 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
|
|
G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions
|
ISO EXP
|
[formononetin co-treated with Hydrogen Peroxide] results in increased expression of HMOX1 protein; formononetin promotes the reaction [Hydrogen Peroxide results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [formononetin promotes the reaction [Hydrogen Peroxide results in increased expression of HMOX1 mRNA]]; Wortmannin inhibits the reaction [formononetin promotes the reaction [Hydrogen Peroxide results in increased expression of HMOX1 mRNA]] formononetin inhibits the reaction [Glucose results in decreased expression of HMOX1 mRNA]
|
CTD |
PMID:34077701 PMID:37944786 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G
|
Il17a
|
interleukin 17A
|
multiple interactions
|
ISO
|
formononetin promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL17A mRNA]
|
CTD |
PMID:25583575 |
|
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:23,144,402...23,147,889
|
|
G
|
Il4
|
interleukin 4
|
increases expression
|
ISO
|
formononetin results in increased expression of IL4 mRNA; formononetin results in increased expression of IL4 protein
|
CTD |
PMID:16108819 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]
|
CTD |
PMID:37269934 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [Streptozocin results in increased expression of JUN mRNA]; formononetin inhibits the reaction [Streptozocin results in increased expression of JUN protein]
|
CTD |
PMID:35315182 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:34077701 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:34077701 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein]
|
CTD |
PMID:34077701 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
|
|
G
|
Matn3
|
matrilin 3
|
decreases expression
|
ISO
|
formononetin results in decreased expression of MATN3 mRNA
|
CTD |
PMID:37793997 |
|
NCBI chr 6:31,748,517...31,768,564
Ensembl chr 6:31,748,474...31,768,101
|
|
G
|
Mcl1
|
MCL1 apoptosis regulator, BCL2 family member
|
decreases expression
|
ISO
|
formononetin decreases expression of MCL1 protein in lung
|
RGD |
PMID:32276600 |
RGD:151357000 |
NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:183,219,220...183,222,303
|
|
G
|
Mdm2
|
MDM2 proto-oncogene
|
increases expression
|
EXP
|
formononetin results in increased expression of MDM2 protein
|
CTD |
PMID:28414026 |
|
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
|
|
G
|
Mdm4
|
MDM4 regulator of p53
|
increases expression
|
EXP
|
formononetin results in increased expression of MDM4 protein
|
CTD |
PMID:28414026 |
|
NCBI chr13:46,922,236...47,068,241
Ensembl chr13:44,406,213...44,474,226
|
|
G
|
Mmp9
|
matrix metallopeptidase 9
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [Streptozocin results in increased expression of MMP9 mRNA]; formononetin inhibits the reaction [Streptozocin results in increased expression of MMP9 protein]
|
CTD |
PMID:35315182 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
|
|
G
|
Nfatc1
|
nuclear factor of activated T-cells 1
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [Streptozocin results in increased expression of NFATC1 mRNA]; formononetin inhibits the reaction [Streptozocin results in increased expression of NFATC1 protein]
|
CTD |
PMID:35315182 |
|
NCBI chr18:76,321,386...76,430,997
Ensembl chr18:74,046,904...74,156,028
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions
|
ISO
|
[formononetin co-treated with Hydrogen Peroxide] results in increased expression of NFE2L2 mRNA; formononetin promotes the reaction [Hydrogen Peroxide affects the localization of NFE2L2 protein]; NFE2L2 protein affects the reaction [[formononetin co-treated with Hydrogen Peroxide] results in increased expression of NQO1 mRNA]; NFE2L2 protein affects the reaction [[formononetin co-treated with Hydrogen Peroxide] results in increased expression of TXNRD1 mRNA]; NFE2L2 protein affects the reaction [formononetin promotes the reaction [Hydrogen Peroxide results in increased expression of GCLM mRNA]]; NFE2L2 protein affects the reaction [formononetin promotes the reaction [Hydrogen Peroxide results in increased expression of HMOX1 mRNA]]; Wortmannin inhibits the reaction [formononetin promotes the reaction [Hydrogen Peroxide affects the localization of NFE2L2 protein]] formononetin inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 mRNA]; formononetin inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein]
|
CTD |
PMID:34077701 PMID:37269934 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [CXCL8 protein results in increased phosphorylation of NFKBIA protein]
|
CTD |
PMID:22387535 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
|
|
G
|
Ngf
|
nerve growth factor
|
multiple interactions
|
EXP
|
formononetin inhibits the reaction [Glucose results in decreased expression of NGF mRNA]; formononetin inhibits the reaction [Glucose results in decreased secretion of and results in decreased expression of NGF protein]
|
CTD |
PMID:37944786 |
|
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
|
|
G
|
Nlrp3
|
NLR family, pyrin domain containing 3
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 mRNA]
|
CTD |
PMID:37269934 |
|
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,328,566...44,352,811
|
|
G
|
Nos3
|
nitric oxide synthase 3
|
increases expression multiple interactions
|
EXP
|
formononetin results in increased expression of NOS3 mRNA formononetin results in increased phosphorylation of and results in increased activity of NOS3 protein
|
CTD |
PMID:19570671 |
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
|
|
G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
multiple interactions
|
ISO
|
[formononetin co-treated with Hydrogen Peroxide] results in increased expression of NQO1 mRNA; [formononetin co-treated with Hydrogen Peroxide] results in increased expression of NQO1 protein; NFE2L2 protein affects the reaction [[formononetin co-treated with Hydrogen Peroxide] results in increased expression of NQO1 mRNA]; Wortmannin inhibits the reaction [[formononetin co-treated with Hydrogen Peroxide] results in increased expression of NQO1 mRNA]
|
CTD |
PMID:34077701 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
|
|
G
|
Pgc
|
progastricsin
|
decreases expression
|
ISO
|
formononetin results in decreased expression of PGC mRNA
|
CTD |
PMID:37793997 |
|
NCBI chr 9:13,257,462...13,265,682
Ensembl chr 9:13,257,462...13,265,682
|
|
G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
multiple interactions
|
EXP
|
formononetin inhibits the reaction [Glucose results in decreased expression of PPARGC1A mRNA]; formononetin inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]
|
CTD |
PMID:37944786 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656
|
|
G
|
Prkaa1
|
protein kinase AMP-activated catalytic subunit alpha 1
|
increases phosphorylation multiple interactions
|
ISO
|
formononetin results in increased phosphorylation of PRKAA1 protein Lipopolysaccharides promotes the reaction [formononetin results in increased phosphorylation of PRKAA1 protein]
|
CTD |
PMID:37269934 |
|
NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:54,240,137...54,275,978
|
|
G
|
Prkaa2
|
protein kinase AMP-activated catalytic subunit alpha 2
|
multiple interactions increases phosphorylation
|
ISO
|
Lipopolysaccharides promotes the reaction [formononetin results in increased phosphorylation of PRKAA2 protein]
|
CTD |
PMID:37269934 |
|
NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:119,813,226...119,879,543
|
|
G
|
Prkacb
|
protein kinase cAMP-activated catalytic subunit beta
|
multiple interactions
|
ISO
|
[Lipopolysaccharides co-treated with formononetin] results in increased phosphorylation of PRKACB protein
|
CTD |
PMID:37269934 |
|
NCBI chr 2:238,297,140...238,389,317
Ensembl chr 2:235,636,885...235,726,198
|
|
G
|
Ptgr1
|
prostaglandin reductase 1
|
increases expression
|
ISO
|
[Formononetin cotreated with gallic acid] increases expression of PTGR1 mRNA in hepatocellular carcinoma cells
|
RGD |
PMID:26265982 |
RGD:401959214 |
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]
|
CTD |
PMID:37269934 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
|
|
G
|
Sirt1
|
sirtuin 1
|
multiple interactions
|
EXP
|
formononetin inhibits the reaction [Glucose results in decreased expression of SIRT1 mRNA]; formononetin inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]
|
CTD |
PMID:37944786 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
|
|
G
|
Sirt3
|
sirtuin 3
|
affects binding multiple interactions
|
EXP
|
formononetin binds to SIRT3 protein formononetin inhibits the reaction [Glucose results in decreased expression of SIRT3 mRNA]; formononetin inhibits the reaction [Glucose results in decreased expression of SIRT3 protein]
|
CTD |
PMID:37944786 |
|
NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
|
|
G
|
Slc22a2
|
solute carrier family 22 member 2
|
decreases expression
|
EXP
|
formononetin results in decreased expression of SLC22A2 mRNA
|
CTD |
PMID:28414026 |
|
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:48,121,061...48,163,268
|
|
G
|
Slc6a14
|
solute carrier family 6 member 14
|
decreases expression
|
ISO
|
formononetin results in decreased expression of SLC6A14 mRNA
|
CTD |
PMID:37793997 |
|
NCBI chr X:112,314,643...112,375,412
Ensembl chr X:112,314,691...112,375,096
|
|
G
|
Sod1
|
superoxide dismutase 1
|
multiple interactions
|
EXP
|
formononetin inhibits the reaction [Glucose results in decreased expression of SOD1 mRNA]; formononetin inhibits the reaction [Glucose results in decreased expression of SOD1 protein]
|
CTD |
PMID:37944786 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
|
|
G
|
Sod2
|
superoxide dismutase 2
|
multiple interactions
|
EXP
|
formononetin inhibits the reaction [Glucose results in decreased expression of SOD2 mRNA]; formononetin inhibits the reaction [Glucose results in decreased expression of SOD2 protein]
|
CTD |
PMID:37944786 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
|
|
G
|
Stk11
|
serine/threonine kinase 11
|
multiple interactions
|
ISO
|
[Lipopolysaccharides co-treated with formononetin] results in increased phosphorylation of STK11 protein
|
CTD |
PMID:37269934 |
|
NCBI chr 7:10,225,204...10,241,965
Ensembl chr 7:9,575,269...9,591,315
|
|
G
|
Tagln
|
transgelin
|
decreases expression
|
ISO
|
formononetin results in decreased expression of TAGLN mRNA
|
CTD |
PMID:37793997 |
|
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
|
|
G
|
Tfam
|
transcription factor A, mitochondrial
|
multiple interactions
|
EXP
|
formononetin inhibits the reaction [Glucose results in decreased expression of TFAM mRNA]
|
CTD |
PMID:37944786 |
|
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,356,197...17,368,292
|
|
G
|
Tfb2m
|
transcription factor B2, mitochondrial
|
multiple interactions
|
EXP
|
formononetin inhibits the reaction [Glucose results in decreased expression of TFB2M mRNA]
|
CTD |
PMID:37944786 |
|
NCBI chr13:91,278,889...91,296,709
Ensembl chr13:91,278,898...91,296,657
|
|
G
|
Tlr4
|
toll-like receptor 4
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein]
|
CTD |
PMID:37269934 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
|
|
G
|
Tp53
|
tumor protein p53
|
multiple interactions decreases expression
|
EXP ISO
|
formononetin inhibits the reaction [Cisplatin results in increased expression of TP53 protein] XI-006 inhibits the reaction [formononetin results in decreased expression of TP53 protein]
|
CTD |
PMID:28414026 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
|
|
G
|
Trpv5
|
transient receptor potential cation channel, subfamily V, member 5
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [Streptozocin results in decreased expression of TRPV5 mRNA]
|
CTD |
PMID:35315182 |
|
NCBI chr 4:70,536,432...70,562,743
Ensembl chr 4:70,536,440...70,562,745
|
|
G
|
Trpv6
|
transient receptor potential cation channel, subfamily V, member 6
|
multiple interactions
|
ISO
|
formononetin inhibits the reaction [Streptozocin results in decreased expression of TRPV6 mRNA]
|
CTD |
PMID:35315182 |
|
NCBI chr 4:70,507,347...70,523,013
Ensembl chr 4:70,507,348...70,523,017
|
|
G
|
Txnip
|
thioredoxin interacting protein
|
increases expression
|
ISO
|
formononetin results in increased expression of TXNIP mRNA
|
CTD |
PMID:37793997 |
|
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:184,092,991...184,096,886
|
|
G
|
Txnrd1
|
thioredoxin reductase 1
|
multiple interactions
|
ISO
|
[formononetin co-treated with Hydrogen Peroxide] results in increased expression of TXNRD1 mRNA; [formononetin co-treated with Hydrogen Peroxide] results in increased expression of TXNRD1 protein; NFE2L2 protein affects the reaction [[formononetin co-treated with Hydrogen Peroxide] results in increased expression of TXNRD1 mRNA]; Wortmannin inhibits the reaction [[formononetin co-treated with Hydrogen Peroxide] results in increased expression of TXNRD1 mRNA]
|
CTD |
PMID:34077701 |
|
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
|
|
G
|
Ugt1a1
|
UDP glucuronosyltransferase family 1 member A1
|
increases glucuronidation increases expression
|
ISO
|
UGT1A1 protein results in increased glucuronidation of formononetin formononetin results in increased expression of UGT1A1 mRNA
|
CTD |
PMID:14557274 PMID:37793997 |
|
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
|
|
G
|
Ugt1a9
|
UDP glucuronosyltransferase family 1 member A9
|
increases glucuronidation
|
ISO
|
UGT1A9 protein results in increased glucuronidation of formononetin
|
CTD |
PMID:14557274 |
|
NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:88,713,184...88,808,465
|
|